- 501. Administrative Supplements to Research Grants
- [These provide administrative supplements to existing NIH research grants for the purpose of 1) promote reentry into biomedical and behavioral research careers 2) promote the recruitment of individuals with disabilities into biomedical research careers and 3) attract underrepresented minorities into biomedical and behavioral research. ( NCI )] (UMLS (NCI) C1510815) =Governmental or Regulatory Activity
| - 551. ADR-529/DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0338305) =Therapeutic or Preventive Procedure
|
- 502. AdministrativeContactRoleType
- [A contact role used for business and/or administrative purposes. ( HL7V3.0 )] (UMLS (HL7) C1698902) =Intellectual Product ;
=ContactRoleType;
=organizational contact;
Billing Contact;
Payor Contact | - 552. ADR-529/DOX/TAX
- (UMLS (NCI) C0338280) =Therapeutic or Preventive Procedure ;
|
- 503. AdministrativeGender
- [The gender of a person used for adminstrative purposes (as opposed to clinical gender) ( HL7V3.0 )] (UMLS (HL7) C1550327) =Organism Attribute =CodeSystem;
=F;
Human, Male;
Undifferentiated | - 553. ADRA1A
- [Alpha-1A-adrenergic receptor, encoded by the ADRA1A gene, regulates smooth muscle contraction, cellular growth and apoptosis. Alpha-1-adrenergic receptors (alpha-1-ARs) are members of the G protein-coupled receptor superfamily. There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of which signal through the Gq/11 family of G-proteins and different subtypes show different patterns of activation. This alpha-adrenergic receptor mediates its action by association with g proteins that activate a phosphatidylinositol-calcium second messenger system. Its effect is mediated by G(Q) and G(11) proteins. Alternative splicing of the ADRA1A gene generates 4 transcript variants, which encode 4 different isoforms with distinct C termini but having similar ligand binding properties. Its carboxyl-terminal SER or THR residues may be phosphorylated. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C0389726) =Amino Acid, Peptide, or Protein; Receptor
|
- 504. AdministrativeLocationRoleType
- (UMLS (HL7) C1701923) =Intellectual Product ;
=RoleCode;
| - 554. ADRA1A
- [This gene plays a regulatory role in the growth and proliferation of several cell types. ( NCI )] (UMLS (NCI) C1332026) ADRA1A Gene;
Adrenergic, Alpha-1A-, Receptor Gene;
=Gene or Genome ;
|
- 505. Administrator
- (UMLS (HL7) C1610729) =Intellectual Product =Registered Nurse;
| - 555. ADRA1B
- [Encoded by human protooncogene ADRA1B Gene (GPCR1 Family), 519-aa 56.8-kD Alpha-1B Adrenergic Receptor is a Gq/11-associated integral membrane protein that activates mitogenic PI-calcium second messenger responses and controls vascular tone and systolic blood pressure. ( NCI )] (UMLS (NCI) C0291339) =Amino Acid, Peptide, or Protein; Receptor
|
- 506. ADMINISTRTVE ENCOUNT NEC
- [ ] (UMLS (ICD9CM) C0260847) =Finding
| - 556. ADRA1B
- [This gene is involved in the induction of neoplastic transformation and receptor signaling. ( NCI )] (UMLS (NCI) C1332027) ADRA1B Gene;
Adrenergic, Alpha-1B-, Receptor Gene;
=Gene or Genome ;
|
- 507. ADMINISTRTVE ENCOUNT NOS
- [ ] (UMLS (ICD9CM) C0260849) =Finding
| - 557. ADRA2A
- [Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. These receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. Alpha-2A-adrenergic receptor is encoded by the ADRA2A gene. Both the alpha2A and alpha2C subtypes are required for normal presynaptic control of transmitter release from sympathetic nerves in the heart and from central noradrenergic neurons. The alpha2A subtype inhibits transmitter release at high stimulation frequencies, whereas the alpha2C subtype modulates neurotransmission at lower levels of nerve activity. (From LocusLink, Swiss_Prot and NCI) ( NCI )] (UMLS (NCI) C0391398) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 508. Admission
- [The condition of being allowed to enter; the activity of admitting someone to something. ( NCI )] (UMLS (NCI) C0809949) =Health Care Activity ;
| - 558. ADRA2A
- [This gene plays a role in the regulation of neurotransmitter release from nerves and neurons in the central nervous system. ( NCI )] (UMLS (NCI) C1332028) ADRA2A Gene;
Adrenergic, Alpha-2A-, Receptor Gene;
=Gene or Genome ;
|
- 509. Admission Level of Care Code
- (UMLS (HL7) C1547813) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Acute;
Chronic;
Comatose;
Critical;
Moribund;
Improved | - 559. ADRA2B
- [Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. These receptors have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. The alpha2B subtype, encoded by the ADRA2B gene is associated with eIF-2B, a guanine nucleotide exchange protein that functions in regulation of translation. A polymorphic variant of the alpha2B subtype, which lacks 3 glutamic acids from a glutamic acid repeat element, decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. This polymorphic form is also associated with reduced basal metabolic rate in obese subjects and may therefore contribute to the pathogenesis of obesity. This gene contains no introns in either its coding or untranslated sequences. (From LocusLink) ( NCI )] (UMLS (NCI) C0540641) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 510. Admission Type
- (UMLS (HL7) C1550330) =Classification =HL7 Vocabulary Version 2.5;
=Accident;
Elective;
Newborn (Birth in healthcare facility);
Routine;
Urgent;
Emergency;
Labor and Delivery | - 560. ADRA2B
- [This gene is involved in transcriptional regulation and G protein-coupled receptor signal transduction. ( NCI )] (UMLS (NCI) C1332029) ADRA2B Gene;
Adrenergic, Alpha-2B-, Receptor Gene;
=Gene or Genome ;
|
- 511. Admit Source
- (UMLS (HL7) C1550339) =Classification =HL7 Vocabulary Version 2.5;
=Physician referral;
Clinic referral;
HMO referral;
Transfer from a hospital;
Transfer from a skilled nursing facility;
Transfer from another health care facility;
Emergency room;
Court/law enforcement;
Data Not Available | - 561. ADRB1
- [Encoded by human ADRB1 Gene (GPCR1 Family), 477-aa 51-kDa conserved Beta-1-Adrenergic Receptor is an integral membrane protein receptor for catecholamine epinephrine and norepinephrine neurotransmitters that activates adenylate cyclase through G protein action. ADRB1 phosphorylation by beta-adrenergic receptor kinase mediates receptor desensitization. Agonist and antagonist drugs selective for beta-1 receptors have important applications in clinical medicine. (NCI) ( NCI )] (UMLS (NCI) C0001642) =Amino Acid, Peptide, or Protein; Receptor
|
- 512. Admitted as an inpatient to this hospital
- (UMLS (HL7) C1548210) =Idea or Concept =Discharge Disposition;
| - 562. ADRB2
- [Encoded by human ADRB2 Gene (GPCR Family), Beta-2 Adrenergic Receptor directly associates with one of its effectors, class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A. This signaling complex assembly ensures specific and rapid signaling by this G protein-coupled receptor that stimulates adenylyl cyclase activity. Polymorphisms, point mutations, and/or downregulation of ADRB2 are associated with nocturnal asthma, obesity, and type 2 diabetes. (From LocusLink) ( NCI )] (UMLS (NCI) C0001643) =Amino Acid, Peptide, or Protein; Receptor
|
- 513. admitter
- [The practitioner who is responsible for admitting a patient to a patient encounter. ( HL7V3.0 )] (UMLS (HL7) C1555323) =Professional or Occupational Group =ParticipationAncillary;
| - 563. ADRB2
- [This gene is involved in maintaining the integrity and rate of G protein-coupled receptor signal transduction. ( NCI )] (UMLS (NCI) C1367657) ADRB2 Gene;
Adrenergic, Beta-2-, Receptor, Surface Gene =Gene or Genome ;
|
- 514. Admitting
- (UMLS (HL7) C1546484) =Idea or Concept =Diagnosis Type;
◊ (UMLS (HL7) C1547428) Idea or Concept Provider role; | - 564. ADRBK1
- [Beta-adrenergic receptor kinase 1 (ADRBK1), encoded by the ADRBK1 gene, phosphorylates the beta-2-adrenergic receptor and mediates agonist-specific desensitization observed at high agonist concentrations. ADRBK1, an ubiquitous cytosolic enzyme, translocates from the cytosol to the plasma membrane upon agonist stimulation and specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Heart failure is accompanied by severely impaired beta-adrenergic receptor (beta-AR) function. An important mechanism for the rapid desensitization of beta-AR function is agonist-stimulated receptor phosphorylation by ADRBK1, an enzyme known to be elevated in failing human heart tissue. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart. Inhibition of ADRBK1 is a novel mode of therapy. (From LocusLink) ( NCI )] (UMLS (NCI) C0753114) BARK1;
Beta-Adrenergic Receptor Kinase 1;
BETA-ARK1;
Beta-ARK-1;
EC 2.7.1.126;
G-Protein Coupled Receptor Kinase 2;
GRK2;
=Amino Acid, Peptide, or Protein; Enzyme; Receptor |
- 515. admitting diagnosis
- [Admitting diagnosis are the diagnoses documented for administrative purposes as the basis for a hospital admission. ( HL7V3.0 )] (UMLS (HL7) C1555318) =Intellectual Product =ObservationDiagnosisTypes;
| - 565. ADRBK1
- [This gene is involved in signal transduction. ( NCI )] (UMLS (NCI) C1366490) ADRBK1 Gene;
Adrenergic, Beta, Receptor Kinase 1 Gene =Gene or Genome |
- 516. admitting physician
- [The physician responsible for the admission of a patient to a hospital or other inpatient health institution. The admitting physician evaluates patients, makes admitting decisions and assesses diagnostic and treatment plans. ( NCI )] (UMLS (HL7) C1550497) =Professional or Occupational Group =ParticipationFunction;
| - 566. ADRBK2
- [Adrenergic, Beta, Receptor Kinase 2 (ADRBK2), encoded by the ADRBK2 gene, specifically phosphorylates the agonist-occupied and -activated form of the beta-adrenergic and related G protein-coupled receptors. ADRBK2 regulates desensitization of G protein-coupled receptors. Overall, the ADRBK2 enzyme has 85% amino acid similarity with ADRBK1, with the protein kinase Catalytic Domain Having 95% Similarity. (From Locuslink) ( NCI )] (UMLS (NCI) C0285499) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 517. Admixture
- [1. The act of mixing; mixture. 2. The compound formed by mixing different substances together. 3. That which is mixed with anything. (ARTFL Project: Webster Dictionary, 1913) ( NCI )] (UMLS (NCI) C1510816) =Qualitative Concept
| - 567. ADRBK2
- [This gene plays a role in signal transduction. ( NCI )] (UMLS (NCI) C1332030) ADRBK2 Gene;
Adrenergic, Beta, Receptor Kinase 2 Gene;
=Gene or Genome ;
|
- 518. Adnexal Carcinoma
- [A carcinoma arising from the sebaceous glands, sweat glands, or the hair follicles. Representative examples include sebaceous carcinoma, apocrine carcinoma, eccrine carcinoma, and pilomatrical carcinoma. ( NCI )] (UMLS (NCI) C0206697) =Neoplastic Process =adenocarcinoma;
Neoplasms, Adnexal and Skin Appendage | - 568. Adrenal
- [paired glands situated in the retroperitoneal tissues at the superior pole of each kidney. ( CSP )] (UMLS (HL7) C0001625) =Body Part, Organ, or Organ Component ;
|
- 519. Adnexal Mass
- (UMLS (NCI) C0149614) =Anatomical Abnormality
| - 569. Adrenal
- [active sympathomimetic hormone from the adrenal medulla in most species; it stimulates both the alpha- and beta- adrenergic systems, causes systemic vasoconstriction and gastrointestinal relaxation, stimulates the heart, and dilates bronchi and cerebral vessels; used in treatment of asthma and cardiac failure and to delay absorption of local anesthetics. ( CSP )] (UMLS (NCI) C0014563) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine; Hormone =adrenergic agent;
catecholamine;
Ethanolamines;
vasoconstrictor;
adrenal medulla hormone;
[AU100] SYMPATHOMIMETICS (ADRENERGICS);
[RE102] BRONCHODILATORS, SYMPATHOMIMETIC,INHALATION;
=Adrenaline Hydrochloride;
(.+-.)-Noradrenaline;
DIPIVEFRIN;
epinephryl borate;
EPINEPHRINE,RACEMIC;
Adrenaline Bitartrate;
Adrenaline Hydrochloride;
EPINEPHRINE,RACEMIC;
Adrenaline Bitartrate;
EPINEPHRINE 0.1 MG/ML;
EPINEPHRINE 5 MG/ML;
EPINEPHRINE 0.2 MG/ACTUAT;
EPINEPHRINE 0.15 MG/0.3ML;
EPINEPHRINE 0.3 MG/0.3ML;
EPINEPHRINE 8 %;
EPINEPHRINE 1:200000;
EPINEPHRINE 1:100000;
EPINEPHRINE 1:50000;
|
- 520. Adnexal Neoplasm of skin
- (UMLS (NCI) C0345988) =Neoplastic Process
| - 570. Adrenal Agent
- [Pharmacological agents which affect the function of the adrenal glands. ( NCI )] (UMLS (NCI) C0280077) =Pharmacologic Substance
|
- 521. adnexitis
- [Inflammation of the uterine appendages (ADNEXA UTERI) including infection of the FALLOPIAN TUBES (SALPINGITIS), the ovaries (OOPHORITIS), or the supporting ligaments (PARAMETRITIS). ( MSH )] (UMLS (CSP) C0001577) =Disease or Syndrome ;
| - 571. Adrenal Artery
- (UMLS (NCI) C0226407) =Body Part, Organ, or Organ Component
|
- 522. ADOLES POSTURAL KYPHOSIS
- [ ] (UMLS (ICD9CM) C0158497) =Acquired Abnormality; Disease or Syndrome
| - 572. Adrenal Blockade
- [Treatment to block production of adrenal hormones. ( NCI )] (UMLS (NCI) C0279034) =Therapeutic or Preventive Procedure
|
- 523. ADOLESCENCE GROWTH NEC
- [ ] (UMLS (ICD9CM) C0029575) =Finding
| - 573. adrenal cancer
- [A primary or metastatic malignant neoplasm affecting the adrenal gland. (NCI05) ( NCI )] (UMLS (CSP) C0750887) MALIGN NEOPL ADRENAL;
Malignant Adrenal Gland Neoplasm;
Malignant Adrenal Gland Tumor;
Malignant Adrenal Neoplasm;
Malignant Adrenal Tumor;
Malignant Neoplasm of Adrenal Gland;
Malignant Neoplasm of the Adrenal Gland;
Malignant Tumor of Adrenal Gland;
Malignant Tumor of the Adrenal Gland =Neoplastic Process ;
|
- 524. Adolescent
- [A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI) ( NCI )] (UMLS (NCI) C0205653) =Age Group ;
=Age categories;
| - 574. adrenal circulation
- [ ] (UMLS (CSP) C0597768) =Organ or Tissue Function ;
|
- 525. Adolescent and Children Mental Health
- [An entity, facility, or distinct part of a facility providing diagnostic, treatment, and prescriptive services related to mental and behavioral disorders in children and adolescents. Services may be provided to parents and family members of the patient in the form of conjoint, group, or individual therapy, and education and/or training. ( HL7V3.0 )] (UMLS (HL7) C1552522) =Intellectual Product ;
=Clinic/Center;
| - 575. Adrenal Cortex
- [The outer layer of the adrenal gland. It secretes mineralocorticoids, androgens, and glucocorticoids. (MeSH) ( NCI )] (UMLS (NCI) C0001613) =Body Part, Organ, or Organ Component ;
|
- 526. Adolescent Medicine
- (UMLS (HL7) C1555745) =Professional or Occupational Group =Family Practice;
◊ (UMLS (HL7) C1555752) Professional or Occupational Group Internal Medicine; ◊ (UMLS (HL7) C1555827) Professional or Occupational Group Pediatrics; | - 576. Adrenal Cortex Adenocarcinoma
- [A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells. Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women. Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes. Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival. ( NCI )] (UMLS (NCI) C0206686) =Neoplastic Process ;
=adenocarcinoma;
Adrenal Cortex Tumor |
- 527. adopted
- [The name the person was given at the time of adoption. ( HL7V3.0 )] (UMLS (HL7) C1552574) =Idea or Concept =PersonNamePartChangeQualifier;
| - 577. Adrenal Cortex Clear Cell Adenoma
- [An adenoma of the adrenal cortex composed of neoplastic clear cells containing intracytoplasmic lipid droplets. ( NCI )] (UMLS (NCI) C0334334) =Neoplastic Process
|
- 528. Adopted
- [Having been legally made a member of a family. ( NCI )] (UMLS (NCI) C0425382) =Finding
| - 578. Adrenal Cortex Compact Cell Adenoma
- [An adenoma of the adrenal cortex composed of neoplastic compact cells with eosinophilic cytoplasm. ( NCI )] (UMLS (NCI) C0334332) =Neoplastic Process
|
- 529. adopted child
- [ ] (UMLS (CSP) C0337541) =Family Group
| - 579. Adrenal Cortex Glomerulosa Cell Adenoma
- [An adenoma of the adrenal cortex composed of neoplastic cells with cytologic features of glomerulosa cells. ( NCI )] (UMLS (NCI) C0334335) =Neoplastic Process
|
- 530. adopted child
- [A child taken into one's family through legal means and raised as one's own child. ( HL7V3.0 )] (UMLS (HL7) C1609059) =Intellectual Product ;
=Child;
CoverageRoleType =adopted son;
adopted daughter | - 580. adrenal cortex hormone
- [any of the 21-carbon steroids elaborated by the adrenal cortex (excluding the sex hormones of adrenal origin) in response to adrenocorticotropic hormone (ACTH) released by the pituitary gland or to angiotensin II; called also adrenocorticoid, corticoid, adrenal cortical or adrenocortical steroid, and adrenocortical or cortical hormone. ( CSP )] (UMLS (CSP) C0001617) =Steroid; Pharmacologic Substance; Hormone ;
|
- 531. adopted daughter
- [The player of the role is a female child taken into a family through legal means and raised by the scoping person (parent) as his or her own child. ( HL7V3.0 )] (UMLS (HL7) C1610723) =Intellectual Product =adopted child;
| - 581. Adrenal Cortex Hyperplasia
- (UMLS (NCI) C0342494) =Disease or Syndrome ;
|
- 532. Adopted Name
- (UMLS (HL7) C1549653) =Idea or Concept =Name type;
| - 582. Adrenal Cortex Mixed Cell Adenoma
- [An adenoma of the adrenal cortex composed of a mixed neoplastic cellular population, including varying numbers of neoplastic clear and compact cells. ( NCI )] (UMLS (NCI) C0334336) =Neoplastic Process
|
- 533. adopted son
- [The player of the role is a male child taken into a family through legal means and raised by the scoping person (parent) as his or her own child. ( HL7V3.0 )] (UMLS (HL7) C1608515) =Intellectual Product =adopted child;
| - 583. Adrenal Cortex Neoplasm
- [A benign or malignant (primary or metastatic) neoplasm affecting the adrenal cortex. (NCI05) ( NCI )] (UMLS (NCI) C0001618) =Neoplastic Process ;
|
- 534. adoptive cell immunotherapy
- [A technique for enhancing cell-mediated immunity by either artificially increasing the number of specific immunocompetent cells through inoculation of ex-vivo expanded primarily activated cytotoxic lymphocytes, or genetically engineered lymphocytes with enhanced cytotoxic ability, or by altering tumor cells to make them more immunogenic. The concept does not refer to anticancer vaccines and immune modulation through the therapeutic use of cytokines, cell receptors, or other substances ( NCI )] (UMLS (CSP) C0079613) =Therapeutic or Preventive Procedure ;
| - 584. Adrenal Cortical Insufficiency
- [The inability of the adrenal gland to produce adequate amounts of cortisol. ( NCI )] (UMLS (NCI) C0405580) =Disease or Syndrome
|
- 535. Adoptive Transfer
- [Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE). ( MSH )] (UMLS (NCI) C0376518) =Therapeutic or Preventive Procedure
| - 585. Adrenal cortical steroids causing adverse effects in therapeutic use
- [ ] (UMLS (ICD9CM) C0261784) =Injury or Poisoning
|
- 536. Adozelesin
- [An alkylating agent that bind to the DNA minor groove in a sequence-specific manner and form covalent adducts with adenines, resulting in the inhibition of DNA replication and induction of apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0077640) =Organic Chemical; Pharmacologic Substance ;
| - 586. Adrenal Cyst
- (UMLS (NCI) C0342501) =Finding
|
- 537. ADP
- [data processing performed by automatic means; typically by computer. ( CSP )] (UMLS (CSP) C0004374) =Machine Activity ;
| - 587. adrenal disorder
- [pathologic condition or abnormal functioning of either or both of the paired glands situated in the retroperitoneal tissues at the superior pole of the kidneys or adrenal glands. ( CSP )] (UMLS (CSP) C0001621) =Disease or Syndrome ;
|
- 538. ADP ribosylation
- [covalent ligation of a protein or other substrate to the ADP-ribose (adenine-ribose-P-P-ribose) obtained by splitting off the nicotinamide from NADH; important in polynucleotide biosynthesis, G protein systems, and pertussis and cholera toxin actions. ( CSP )] (UMLS (CSP) C0596043) =Phenomenon or Process ;
=Glycosylation;
| - 588. ADRENAL DISORDER NEC
- [ ] (UMLS (ICD9CM) C0154207) =Disease or Syndrome
|
- 539. ADP ribosyltransferase
- [Enzymes that transfer the ADP-RIBOSE group of NAD or NADP to proteins or other small molecules. Transfer of ADP-ribose to water (i.e., hydrolysis) is catalyzed by the NADASES. The mono(ADP-ribose)transferases transfer a single ADP-ribose. POLY(ADP-RIBOSE) POLYMERASES transfer multiple units of ADP-ribose to protein targets, building POLY ADENOSINE DIPHOSPHATE RIBOSE in linear or branched chains. ( MSH )] (UMLS (CSP) C0085748) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 589. ADRENAL EXPLORATION NOS
- [ ] (UMLS (ICD9CM) C0405570) =Diagnostic Procedure
|
- 540. ADR
- [Indicates that the observation is of an unexpected negative occurrence in the subject suspected to result from the subject's exposure to one or more agents. Observation values would be the symptom resulting from the reaction. ( HL7V3.0 )] (UMLS (NCI) C0559546) =Finding =ObservationType;
| - 590. adrenal ferredoxin
- [iron-sulfur protein which serves as an electron carrier in enzymatic steroid hydroxylation reactions in adrenal cortex mitochondria. ( CSP )] (UMLS (CSP) C0596044) =Organic Chemical ;
=ferredoxin;
|
- 541. ADR-529
- (UMLS (NCI) C0733405) =Organic Chemical; Pharmacologic Substance
| - 591. Adrenal Ganglioneuroblastoma
- [A ganglioneuroblastoma arising from the adrenal gland. ( NCI )] (UMLS (NCI) C1332176) Adrenal Gland Ganglioneuroblastoma;
=Neoplastic Process |
- 542. ADR-529/ASP/DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0338303) =Therapeutic or Preventive Procedure
| - 592. Adrenal Gland Abscess
- (UMLS (NCI) C0919935) =Pathologic Function
|
- 543. ADR-529/ASP/DOX/MP/PRED/VCR
- (UMLS (NCI) C0338302) =Therapeutic or Preventive Procedure
| - 593. ADRENAL GLAND ANOMALY
- [ ] (UMLS (ICD9CM) C0158797) =Congenital Abnormality
|
- 544. ADR-529/BLEO/CTX/DOX/PRED/VCR/VP-16
- (UMLS (NCI) C0677847) =Therapeutic or Preventive Procedure ;
| - 594. Adrenal Gland Capsule
- (UMLS (NCI) C1181304) =Body Part, Organ, or Organ Component ;
|
- 545. ADR-529/BLEO/DOX/VCR/VP-16
- (UMLS (NCI) C0392942) =Therapeutic or Preventive Procedure ;
| - 595. Adrenal Gland Chromaffin Paraganglioma
- [usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the adrenal medulla or sympathetic paraganglia; the cardinal symptom, reflecting the increased secretion of epinephrine and norepinephrine, is hypertension, which may be persistent or intermittent. ( CSP )] (UMLS (NCI) C0031511) =Neoplastic Process ;
=Adrenal Gland Neoplasm;
Neoplasm of Paraganglion |
- 546. ADR-529/CTX/DOX/5-FU
- (UMLS (NCI) C0279446) =Therapeutic or Preventive Procedure
| - 596. Adrenal Gland Excision
- [excision of one (unilateral) or both (bilateral) of the adrenal glands; called also suprarenalectomy. ( CSP )] (UMLS (NCI) C0001632) =Therapeutic or Preventive Procedure ;
|
- 547. ADR-529/CTX/DOX/VCR
- (UMLS (NCI) C0279414) =Therapeutic or Preventive Procedure
| - 597. Adrenal Gland Injury
- (UMLS (NCI) C0347637) =Injury or Poisoning
|
- 548. ADR-529/DOX
- (UMLS (NCI) C0281254) =Therapeutic or Preventive Procedure ;
| - 598. ADRENAL GLAND INJURY-CL
- [ ] (UMLS (ICD9CM) C0160445) =Injury or Poisoning
|
- 549. ADR-529/DOX/G-CSF/TAX
- (UMLS (NCI) C0338281) =Therapeutic or Preventive Procedure ;
| - 599. ADRENAL GLAND INJURY-OPN
- [ ] (UMLS (ICD9CM) C0160452) =Injury or Poisoning
|
- 550. ADR-529/DOX/GM-CSF
- (UMLS (NCI) C0279104) =Therapeutic or Preventive Procedure
| - 600. Adrenal Gland Myelolipoma
- [A benign soft tissue lesion arising from the adrenal gland. It is composed of mature adipose and hematopoietic/lymphoid tissues. ( NCI )] (UMLS (NCI) C0206635) =Neoplastic Process =Adipose Tissue Neoplasm;
|
home
